Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Status
- RECRUITING
- Phase
- PHASE2
Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP)
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
- Status
- TERMINATED
- Phase
- NA
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)
- Status
- UNKNOWN
- Phase
- N/A
Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
CBT on Fatigue in Survivors of Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- NA
A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx
- Status
- COMPLETED
- Phase
- NA
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Status
- COMPLETED
- Phase
- NA
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1